Our observations have potential clinical implications, as the assessment of a specific pattern of p16Ink4A expression in a small area of the tumor could provide information on the biological aggressiveness of each individual lung neoplasm. The gene discussed is CDKN2A; the disease is Neoplasm of the lung.